Long pages

Jump to navigation Jump to search

Showing below up to 50 results in range #52,351 to #52,400.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. (hist) Ebola history and symptoms [3,708 bytes]
  2. (hist) Hallucination (patient information) [3,708 bytes]
  3. (hist) The Living Guidelines: Pregnant patients: Suggest Revisions to the CLASS I Guidelines [3,708 bytes]
  4. (hist) Michael Festing [3,708 bytes]
  5. (hist) Lactococcus lactis [3,708 bytes]
  6. (hist) Theobromine poisoning [3,708 bytes]
  7. (hist) Polysulfone [3,708 bytes]
  8. (hist) Bile duct [3,708 bytes]
  9. (hist) Hepatotoxicity epidemiology and demographics [3,707 bytes]
  10. (hist) Amenorrhea CT [3,707 bytes]
  11. (hist) Abdominal aortic aneurysm prevention [3,707 bytes]
  12. (hist) Sunnyside Hospital [3,707 bytes]
  13. (hist) Kent C. Berridge [3,707 bytes]
  14. (hist) Tricholomataceae [3,707 bytes]
  15. (hist) Postpartum thyroiditis epidemiology and demographics [3,706 bytes]
  16. (hist) Ischemic colitis other diagnostic studies [3,706 bytes]
  17. (hist) Cyfluthrin [3,706 bytes]
  18. (hist) Bursitis other diagnostic studies [3,706 bytes]
  19. (hist) Pleurisy (patient information) [3,706 bytes]
  20. (hist) Cluster decay [3,706 bytes]
  21. (hist) Portal:Health and fitness [3,706 bytes]
  22. (hist) SOX17 [3,705 bytes]
  23. (hist) ZNF22 [3,705 bytes]
  24. (hist) Short bowel syndrome physical examination [3,705 bytes]
  25. (hist) Cystic fibrosis historical perspective [3,705 bytes]
  26. (hist) Akuammine [3,705 bytes]
  27. (hist) Acireductone dioxygenase (Ni2+-requiring) [3,705 bytes]
  28. (hist) Euglossini [3,705 bytes]
  29. (hist) European Pharmaceutical Union [3,705 bytes]
  30. (hist) Unsealed source radiotherapy [3,705 bytes]
  31. (hist) GLOD4 [3,704 bytes]
  32. (hist) STOML1 [3,704 bytes]
  33. (hist) Uterine mass causes [3,704 bytes]
  34. (hist) Hepatitis D ultrasound [3,704 bytes]
  35. (hist) MC-1 does not reduce cardiovascular and cerebrovascular events in the phase 3 MEND-CABG II trial [3,704 bytes]
  36. (hist) MC-1 does not reduce cardiovascular and cerebrovascular events in phase 3 MEND-CABG II trial [3,704 bytes]
  37. (hist) Methanobacterium [3,704 bytes]
  38. (hist) Gordon Zubrod [3,704 bytes]
  39. (hist) Oxamniquine [3,704 bytes]
  40. (hist) Copper chromite [3,704 bytes]
  41. (hist) Betanin [3,704 bytes]
  42. (hist) The Best System You Should Be Using For Sand Casting [3,703 bytes]
  43. (hist) KANSL3 [3,703 bytes]
  44. (hist) WBR1045 [3,703 bytes]
  45. (hist) WBR0336 [3,703 bytes]
  46. (hist) Acute bronchitis differential diagnosis [3,703 bytes]
  47. (hist) Vytorin how supplied [3,703 bytes]
  48. (hist) SLC25A39 [3,703 bytes]
  49. (hist) Potato spindle tuber viroid [3,703 bytes]
  50. (hist) Congenital heart block (patient information) [3,702 bytes]

View ( | ) (20 | 50 | 100 | 250 | 500)